AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35227647 — intervention group
Group type: COMPARATOR
Intervention: Inhaled AZD5634 (up to 1700 µg)
Number of subjects: 64
Study 35227647 — intervention group
Group type: COMPARATOR
Intervention: Inhaled AZD5634
Number of subjects: 64
Study 34261371 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg lozenges
Number of subjects: 24
Study 34261371 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 24
Study 35730885 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnoy's solution (CS)
Number of subjects: 60
Study 35730885 — intervention group
Group type: COMPARATOR
Intervention: 10% neutral buffered formalin (NBF)
Number of subjects: 60
Study 34580379 — intervention group
Group type: COMPARATOR
Intervention: I1: 100‐90% (control)
Number of subjects: 3
Study 34580379 — intervention group
Group type: EXPERIMENTAL
Intervention: I2: 80‐70%
Number of subjects: 3
Study 34580379 — intervention group
Group type: EXPERIMENTAL
Intervention: I3: 60‐50%
Number of subjects: 3
Study 34580379 — intervention group
Group type: EXPERIMENTAL
Intervention: I4: 30‐40%
Number of subjects: 3
Study 35610627 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Worker Health (TWH) leadership development program
Number of subjects: 250
Study 35610627 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlisted)
Number of subjects: 250
Study 33795257 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 77
Study 33795257 — intervention group
Group type: COMPARATOR
Intervention: Dacarbazine
Number of subjects: 77
Study 34399547 — intervention group
Group type: EXPERIMENTAL
Intervention: L-cysteine hydrochloride; concentration 4.23 mM at pH 8.71
Number of subjects: 0
Study 34399547 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutathione (GSH); concentration 3.78 mM at pH 8.51
Number of subjects: 0
Study 34399547 — intervention group
Group type: COMPARATOR
Intervention: Control (no added thiols); pH 8.9-9.3
Number of subjects: 0
Study 34399547 — intervention group
Group type: COMPARATOR
Intervention: Control (0.82 mM thiols); pH 10.41
Number of subjects: 0
Study 35686393 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enhanced physical activity intervention (bi-weekly education sessions for 4 weeks, monthly small group walks for 8 weeks, weekly reminder text messages)
Number of subjects: 43
Study 32921337 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (40‐160 mg/d)
Number of subjects: 0
Study 32921337 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 0
Study 32921337 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine XR
Number of subjects: 0
Study 32921337 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0
Study 32921337 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (after switching from olanzapine or risperidone)
Number of subjects: 0
Study 36261491 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel group (poloxamer 407‐based 0.75% ropivacaine, 22.5 mg)
Number of subjects: 61
Study 36261491 — intervention group
Group type: COMPARATOR
Intervention: On-Q group (0.2% ropivacaine, 4 mg/hour for two days)
Number of subjects: 61
Study 36261491 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel group
Number of subjects: 61
Study 36261491 — intervention group
Group type: COMPARATOR
Intervention: On-Q group
Number of subjects: 61
Study 34193128 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on palliative care competencies and communication skills addressing end‐of‐life issues
Number of subjects: 8
Study 32144166 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalcetrapib 600 mg daily
Number of subjects: 15671
Study 32144166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15671
Study 35927674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of 10^7 umbilical cord-derived Wharton's jelly mesenchymal stem cells (WJ-MSCs)
Number of subjects: 390
Study 35927674 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 390
Study 33326348 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Support Tool
Number of subjects: 52
Study 33326348 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 52
Study 33387811 — intervention group
Group type: EXPERIMENTAL
Intervention: Online decision aid
Number of subjects: 250
Study 35582785 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan-bupropion (45 mg/105 mg tablet)
Number of subjects: 80
Study 35582785 — intervention group
Group type: COMPARATOR
Intervention: Bupropion (105 mg tablet)
Number of subjects: 80
Study 35582785 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan-bupropion
Number of subjects: 80
Study 35582785 — intervention group
Group type: COMPARATOR
Intervention: Bupropion
Number of subjects: 80
Study 33546656 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified Blended Approach
Number of subjects: 238
Study 33546656 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 238
Study 33864432 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei (1 × 10^10 CFU/day)
Number of subjects: 429
Study 33864432 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei (2 × 10^10 CFU/day)
Number of subjects: 429
Study 33864432 — intervention group
Group type: COMPARATOR
Intervention: Standard tuberculosis therapy alone
Number of subjects: 429
Study 34049428 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated neuromuscular inhibition technique (INIT)
Number of subjects: 48
Study 34049428 — intervention group
Group type: COMPARATOR
Intervention: Positional release technique (PRT)
Number of subjects: 48
Study 34695552 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral carotid artery stenting (CAS)
Number of subjects: 2544
Study 34695552 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 2544
Study 34695552 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS
Number of subjects: 2544
Study 34695552 — intervention group
Group type: COMPARATOR
Intervention: CEA
Number of subjects: 2544
Study 32988969 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 50 mg with enzalutamide 160 mg daily
Number of subjects: 247
Study 32988969 — intervention group
Group type: COMPARATOR
Intervention: Exemestane 25 mg with placebo
Number of subjects: 247
Study 36397443 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-involved smart medication management system
Number of subjects: 82
Study 36397443 — intervention group
Group type: COMPARATOR
Intervention: Routine medication management model
Number of subjects: 82
Study 33297821 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct TAVR group (no prior balloon aortic valvuloplasty)
Number of subjects: 211
Study 33297821 — intervention group
Group type: COMPARATOR
Intervention: BAV group (prior balloon aortic valvuloplasty)
Number of subjects: 211
Study 33297821 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 211
Study 35568805 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based physiotherapy training programme at home for nine months
Number of subjects: 230
Study 35568805 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 230
Study 34787449 — intervention group
Group type: EXPERIMENTAL
Intervention: MenABCWY vaccine
Number of subjects: 500
Study 34787449 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB+ACWY/S group
Number of subjects: 500
Study 34787449 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB+ACWY/D group
Number of subjects: 500
Study 34787449 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB group
Number of subjects: 500
Study 33983107 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat germ (20 g)
Number of subjects: 80
Study 33983107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34337526 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg high-dose estetrol (HDE4) for 24 weeks
Number of subjects: 62
Study 34337526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 36440678 — intervention group
Group type: EXPERIMENTAL
Intervention: Online counseling education program (7-hours self-directed learning; 3-hour online workshop)
Number of subjects: 49
Study 33206257 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic antibiotics (PA)
Number of subjects: 64
Study 33206257 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulin replacement therapy (IRT)
Number of subjects: 64
Study 32308117 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 160
Study 32308117 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive social interaction (partner appraisal task)
Number of subjects: 160
Study 32308117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 34259591 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificially generated double inversion recovery images (aDIR)
Number of subjects: 73
Study 34259591 — intervention group
Group type: COMPARATOR
Intervention: Conventionally acquired double inversion recovery images (cDIR)
Number of subjects: 73
Study 34261076 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP subcutaneous injection
Number of subjects: 200
Study 34261076 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 35894919 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised concurrent (aerobic + resistance) exercise program, 3 days/week
Number of subjects: 101
Study 35894919 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study 35894919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 101
Study 35894919 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing cardiorespiratory fitness, muscle strength, and sleep duration
Number of subjects: 101
Study 33428631 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter (OTC) medications for CIC, including bisacodyl (33%) and polyethylene glycol (30%)
Number of subjects: 1423
Study 35988193 — intervention group
Group type: EXPERIMENTAL
Intervention: LEEP under propofol intravenous anesthesia combined with nano-silver gel
Number of subjects: 100
Study 35988193 — intervention group
Group type: COMPARATOR
Intervention: LEEP under intravenous anesthesia with fentanyl
Number of subjects: 100
Study 34074227 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks of eccentric hamstring training at long muscle length
Number of subjects: 34
Study 34074227 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 34
Study 34928443 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher average OA z-score
Number of subjects: 281
Study 34928443 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher PC3
Number of subjects: 281
Study 34928443 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylmalonate, citrate/isocitrate, ethylmalonate, lactate
Number of subjects: 281
Study 36028847 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 280
Study 36028847 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 280
Study 33819489 — intervention group
Group type: EXPERIMENTAL
Intervention: Star‐shape Kinesio taping (KT)
Number of subjects: 120
Study 33819489 — intervention group
Group type: COMPARATOR
Intervention: Minimal Intervention (MI)
Number of subjects: 120
Study 33819489 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesio taping (KT)
Number of subjects: 120
Study 35264362 — intervention group
Group type: COMPARATOR
Intervention: 0 mg iron supplementation (placebo)
Number of subjects: 1200
Study 35264362 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg iron supplementation
Number of subjects: 1200
Study 35264362 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg iron supplementation
Number of subjects: 1200
Study 35264362 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation on alternate days
Number of subjects: 1200
Study 35264362 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation daily for 56 days
Number of subjects: 1200
Study 32301028 — intervention group
Group type: COMPARATOR
Intervention: Anodal tDCS (10-day intervention)
Number of subjects: 44
Study 32301028 — intervention group
Group type: COMPARATOR
Intervention: Anodal tDCS (10 days a month for 8 months)
Number of subjects: 44
Study 32091670 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (ST) twice a week for 10 weeks
Number of subjects: 34
Study 32091670 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group (CON)
Number of subjects: 34
Study 35976462 — intervention group
Group type: EXPERIMENTAL
Intervention: Text reminder with specific scheduling options
Number of subjects: 1277
Study 35976462 — intervention group
Group type: EXPERIMENTAL
Intervention: Text reminder with open-ended scheduling options
Number of subjects: 1277
Study 35976462 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1277
Study 35976462 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based reminder and scheduling opportunity
Number of subjects: 1277
Study 33449326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine gel pre and post flexible cystoscopy
Number of subjects: 50
Study 33449326 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine gel pre flexible cystoscopy only
Number of subjects: 50
Study 34242472 — intervention group
Group type: EXPERIMENTAL
Intervention: Supratherapeutic venlafaxine 450 mg/d
Number of subjects: 54
Study 34242472 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 54
Study 34242472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 34715839 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mL 2%‐lidocaine intracervical block
Number of subjects: 100
Study 34715839 — intervention group
Group type: COMPARATOR
Intervention: 550 mg naproxen
Number of subjects: 100
Study 34715839 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine intracervical block
Number of subjects: 100
Study 34715839 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 100
Study 32421854 — intervention group
Group type: EXPERIMENTAL
Intervention: VT-1161 300 mg (2-week daily dose, followed by once-weekly for 10 or 22 weeks)
Number of subjects: 259
Study 32421854 — intervention group
Group type: EXPERIMENTAL
Intervention: VT-1161 600 mg (2-week daily dose, followed by once-weekly for 10 or 22 weeks)
Number of subjects: 259
Study 32421854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 33408039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented Oxford UKR
Number of subjects: 39
Study 33408039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless Oxford UKR
Number of subjects: 39
Study 33408039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless tibial component
Number of subjects: 39
Study 33408039 — intervention group
Group type: COMPARATOR
Intervention: Cemented tibial component
Number of subjects: 39
Study 33408039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless tibial components
Number of subjects: 39
Study 33408039 — intervention group
Group type: COMPARATOR
Intervention: Cemented tibial components
Number of subjects: 39
Study 33754923 — intervention group
Group type: EXPERIMENTAL
Intervention: Red spinach extract (RSE) 2g daily (180mg nitrate)
Number of subjects: 16
Study 33754923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/4 lower-energy options on fuller shelves
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 3/4 lower-energy options on fuller shelves
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/4 lower-energy options on emptier shelves
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 3/4 lower-energy options on emptier shelves
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 2/3 lower-energy snacks on fuller trays
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/3 lower-energy snacks on fuller trays
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/3 lower-energy snacks on emptier trays
Number of subjects: 2479
Study 33836216 — intervention group
Group type: EXPERIMENTAL
Intervention: 2/3 lower-energy snacks on emptier trays
Number of subjects: 2479
Study 33491787 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral potassium and magnesium supplements administered pre-procedure based on pre-electrolyte levels.
Number of subjects: 136
Study 33491787 — intervention group
Group type: COMPARATOR
Intervention: Historic cohort (2010-2013) without electrolyte intervention.
Number of subjects: 136
Study 32269534 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIT-VR therapy delivered through the virtual world platform Second Life©, 8 sessions over a 5-week intervention window.
Number of subjects: 15
Study 33632476 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr) plus GDMT
Number of subjects: 614
Study 33632476 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 614
Study 33632476 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone followed by TMVr (crossover group)
Number of subjects: 614
Study 33115527 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized statistical process control (SPC) charts for SSI surveillance and feedback
Number of subjects: 105
Study 33115527 — intervention group
Group type: COMPARATOR
Intervention: Traditional surveillance for SSIs
Number of subjects: 105
Study 35183469 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative CPN
Number of subjects: 70
Study 35183469 — intervention group
Group type: COMPARATOR
Intervention: CT-guided CPN
Number of subjects: 70
Study 33413593 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 276
Study 33413593 — intervention group
Group type: COMPARATOR
Intervention: Restrictive Fluid Therapy combined with Enhanced Recovery After Surgery (ERAS) protocol
Number of subjects: 276
Study 33478409 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Worry Scale (CWS)
Number of subjects: 50
Study 33478409 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Management Skill Scale (SMSS)
Number of subjects: 50
Study 35893335 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time feedback device
Number of subjects: 72
Study 35893335 — intervention group
Group type: COMPARATOR
Intervention: Control (no feedback)
Number of subjects: 72
Study 32613871 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 73
Study 32613871 — intervention group
Group type: COMPARATOR
Intervention: Popular science program (Control)
Number of subjects: 73
Study 32796546 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids, β-alanine, and carnosine intake from a diet with 55% carbohydrate, 30% fat, and 15% protein for 14 days followed by gravity-independent resistive exercise.
Number of subjects: 21
Study 35653696 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved cookstoves
Number of subjects: 4010
Study 35653696 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved cookstoves (subset analysis)
Number of subjects: 4010
Study 35653696 — intervention group
Group type: COMPARATOR
Intervention: Control (open fires or highly polluting cookstoves)
Number of subjects: 4010
Study 32077071 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated task set group (one task set)
Number of subjects: 0
Study 32077071 — intervention group
Group type: COMPARATOR
Intervention: Separate task set group (two task sets)
Number of subjects: 0
Study 34542204 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina-fortified dressing (2 g of spirulina platensis powder)
Number of subjects: 48
Study 34542204 — intervention group
Group type: COMPARATOR
Intervention: Placebo dressing
Number of subjects: 48
Study 35527689 — intervention group
Group type: EXPERIMENTAL
Intervention: Battlefield Acupuncture (BFA)
Number of subjects: 72
Study 35527689 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 72
Study 33293319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) including total dietary replacement phase using meal replacement products, followed by staged food reintroduction and physical activity support.
Number of subjects: 147
Study 33293319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 147
Study 33293319 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 147
Study 35830312 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postextraction implants with grafting the bone‐to‐implant gap (Group A)
Number of subjects: 0
Study 35830312 — intervention group
Group type: COMPARATOR
Intervention: Delayed implants inserted after alveolar ridge preservation (Group B)
Number of subjects: 0
Study 33624548 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 30
Study 33624548 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 30
Study 33624548 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 30
Study 32799804 — intervention group
Group type: EXPERIMENTAL
Intervention: Bothersome ED
Number of subjects: 2888
Study 35712259 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump with independent intermittent scanning continuous glucose monitoring (iscCGM, Freestyle libre ®)
Number of subjects: 31
Study 35712259 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor augmented pump (SAP) with predictive low glucose suspend (SmartGuard®)
Number of subjects: 31
Study 35712259 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment preference after one year
Number of subjects: 31
Study 35108185 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage treatment protocol
Number of subjects: 0
Study 35108185 — intervention group
Group type: COMPARATOR
Intervention: Two-stage treatment protocol
Number of subjects: 0